XML 53 R42.htm IDEA: XBRL DOCUMENT v3.24.2.u1

Segment Information (Tables)

6 Months Ended

Jun. 30, 2024

Segment Information [Abstract]

Schedule of Segment Information

		During the Three-Month Period Ended June 30, 2024
		Scours				Mastitis				Other				Total
Product sales		$	5,430,069			$	42,821			$	—			$	5,472,890
Costs of goods sold			4,198,849				43,555				—				4,242,404
Gross margin			1,231,220				(734	)			—				1,230,486
Product development expense			65,598				928,531				36,373				1,030,502
Sales and marketing expenses			855,513				129,444				—				984,957
Administrative expenses			—				—				601,634				601,634
Operating expenses			921,111				1,057,975				638,007				2,617,093
NET OPERATING INCOME (LOSS)		$	310,109			$	(1,058,709	)		$	(638,007	)		$	(1,386,607	)

		During the Three-Month Period Ended June 30, 2023
		Scours				Mastitis				Other				Total
Product sales		$	3,482,259			$	50,422			$	—			$	3,532,681
Costs of goods sold			2,453,169				35,624				—				2,488,793
Gross margin			1,029,090				14,798				—				1,043,888
Product development expenses			2,252				1,061,383				35,903				1,099,538
Sales and marketing expenses			558,179				161,610				—				719,789
Administrative expenses			—				—				529,056				529,056
Operating expenses			560,431				1,222,993				564,959				2,348,383
NET OPERATING INCOME (LOSS)		$	468,659			$	(1,208,195	)		$	(564,959	)		$	(1,304,495	)

		Scours				Mastitis				Other				Total
Total Assets as of June 30, 2024		$	23,240,545			$	17,107,377			$	1,507,536			$	41,855,458
Total Assets as of June 30, 2023		$	23,910,633			$	18,374,662			$	1,721,773			$	44,007,068
Depreciation and amortization expense during the three-month period ended June 30, 2024		$	342,362			$	319,727			$	19,676			$	681,765
Depreciation and amortization expense during the three-month period ended June 30, 2023		$	341,979			$	323,661			$	21,074			$	686,714
Capital Expenditures during the three-month period ended June 30, 2024		$	93,338			$	17,403			$	—			$	110,741
Capital Expenditures during the three-month period ended June 30, 2023		$	124,911			$	583,577			$	—			$	708,488

		During the Six-Month Period Ended June 30, 2024
		Scours				Mastitis				Other				Total
Product sales		$	12,650,710			$	79,757			$	—			$	12,730,467
Costs of goods sold			9,122,397				82,225				—				9,204,622
Gross margin			3,528,313				(2,468	)			—				3,525,845
Product development expense			95,093				2,131,473				66,487				2,293,053
Sales and marketing expenses			1,525,252				260,628				—				1,785,880
Administrative expenses			—				—				1,133,572				1,133,572
Operating expenses			1,620,345				2,392,101				1,200,059				5,212,505
NET OPERATING INCOME (LOSS)		$	1,907,968			$	(2,394,569	)		$	(1,200,059	)		$	(1,686,660	)

		During the Six-Month Period Ended June 30, 2023
		Scours				Mastitis				Other				Total
Product sales		$	6,893,491			$	85,716			$	—			$	6,979,207
Costs of goods sold			5,557,127				77,417				—				5,634,544
Gross margin			1,336,364				8,299				—				1,344,663
Product development expenses			2,543				2,137,728				69,636				2,209,907
Sales and marketing expenses			1,248,723				350,493				—				1,599,216
Administrative expenses			—				—				1,096,074				1,096,074
Operating expenses			1,251,266				2,488,221				1,165,710				4,905,197
NET OPERATING INCOME (LOSS)		$	85,098			$	(2,479,922	)		$	(1,165,710	)		$	(3,560,534	)

		Scours				Mastitis				Other				Total
Total Assets as of June 30, 2024		$	23,240,545			$	17,107,377			$	1,507,536			$	41,855,458
Total Assets as of June 30, 2023		$	23,910,633			$	18,374,662			$	1,721,773			$	44,007,068
Depreciation and amortization expense during the six-month period ended June 30, 2024		$	681,281			$	638,445			$	39,539			$	1,359,265
Depreciation and amortization expense during the six-month period ended June 30, 2023		$	665,236			$	641,285			$	39,022			$	1,345,543
Capital Expenditures during the six-month period ended June 30, 2024		$	132,812			$	48,285			$	—			$	181,097
Capital Expenditures during the six-month period ended June 30, 2023		$	696,647			$	694,007			$	—			$	1,390,654

		During the Year Ended December 31, 2023
		Scours				Mastitis				Other				Total
Product sales		$	17,293,933			$	177,736			$	—			$	17,471,669
Costs of goods sold			13,453,514				148,871				—				13,602,385
Gross margin			3,840,419				28,865				—				3,869,284
Product development expense			11,103				4,242,329				141,420				4,394,852
Sales and marketing expenses			2,447,137				641,078				—				3,088,215
Administrative expenses			—				—				2,134,295				2,134,295
Operating expenses			2,458,240				4,883,407				2,275,715				9,617,362
NET OPERATING INCOME (LOSS)		$	1,382,179			$	(4,854,542	)		$	(2,275,715	)		$	(5,748,078	)

		During the Year Ended December 31, 2022
		Scours				Mastitis				Other				Total
Product sales		$	18,411,949			$	154,558			$	1,455			$	18,567,962
Costs of goods sold			10,754,189				136,347				28,647				10,919,183
Gross margin			7,657,760				18,211				(27,192	)			7,648,779
Product development expenses			66,346				4,317,921				109,605				4,493,872
Sales and marketing expenses			1,871,926				1,318,107				—				3,190,033
Administrative expenses			—				—				2,263,817				2,263,817
Operating expenses			1,938,272				5,636,028				2,373,422				9,947,722
NET OPERATING INCOME (LOSS)		$	5,719,488			$	(5,617,817	)		$	(2,400,614	)		$	(2,298,943	)

		Scours				Mastitis				Other				Total
Total Assets as of December 31, 2023		$	24,735,413			$	17,827,839			$	1,244,850			$	43,808,102
Total Assets as of December 31, 2022		$	20,539,523			$	18,315,492			$	6,005,634			$	44,860,649
Depreciation and amortization expense during the year ended December 31, 2023		$	1,365,988			$	1,287,600			$	86,032			$	2,739,620
Depreciation and amortization expense during the year ended December 31, 2022		$	1,169,011			$	1,263,318			$	62,912			$	2,495,241
Capital Expenditures during the year ended December 31, 2023		$	1,096,819			$	795,694			$	—			$	1,892,513
Capital Expenditures during the year ended December 31, 2022		$	3,513,336			$	414,486			$	47,452			$	3,975,274

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration